vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and SUNation Energy, Inc. (SUNE). Click either name above to swap in a different company.

SUNation Energy, Inc. is the larger business by last-quarter revenue ($27.2M vs $19.2M, roughly 1.4× Apyx Medical Corp). SUNation Energy, Inc. runs the higher net margin — 9.6% vs -6.8%, a 16.3% gap on every dollar of revenue. On growth, SUNation Energy, Inc. posted the faster year-over-year revenue change (77.0% vs 34.7%). Over the past eight quarters, SUNation Energy, Inc.'s revenue compounded faster (43.5% CAGR vs 36.8%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Suncor Energy Inc. is a Canadian integrated energy company based in Calgary, Alberta. It specializes in production of synthetic crude from oil sands. In the 2020 Forbes Global 2000, Suncor Energy was ranked as the 48th-largest public company in the world.

APYX vs SUNE — Head-to-Head

Bigger by revenue
SUNE
SUNE
1.4× larger
SUNE
$27.2M
$19.2M
APYX
Growing faster (revenue YoY)
SUNE
SUNE
+42.2% gap
SUNE
77.0%
34.7%
APYX
Higher net margin
SUNE
SUNE
16.3% more per $
SUNE
9.6%
-6.8%
APYX
Faster 2-yr revenue CAGR
SUNE
SUNE
Annualised
SUNE
43.5%
36.8%
APYX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
SUNE
SUNE
Revenue
$19.2M
$27.2M
Net Profit
$-1.3M
$2.6M
Gross Margin
62.6%
40.7%
Operating Margin
0.1%
10.7%
Net Margin
-6.8%
9.6%
Revenue YoY
34.7%
77.0%
Net Profit YoY
71.9%
138.2%
EPS (diluted)
$105.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
SUNE
SUNE
Q4 25
$19.2M
$27.2M
Q3 25
$12.9M
$19.0M
Q2 25
$11.4M
$13.1M
Q1 25
$9.4M
$12.6M
Q4 24
$14.2M
$15.4M
Q3 24
$11.5M
$14.7M
Q2 24
$12.1M
$13.5M
Q1 24
$10.2M
$13.2M
Net Profit
APYX
APYX
SUNE
SUNE
Q4 25
$-1.3M
$2.6M
Q3 25
$-2.0M
$-393.0K
Q2 25
$-3.8M
$-9.6M
Q1 25
$-4.2M
$-3.5M
Q4 24
$-4.6M
$-6.8M
Q3 24
$-4.7M
$-3.3M
Q2 24
$-6.6M
$-6.9M
Q1 24
$-7.6M
$1.2M
Gross Margin
APYX
APYX
SUNE
SUNE
Q4 25
62.6%
40.7%
Q3 25
64.4%
38.0%
Q2 25
62.3%
37.0%
Q1 25
60.1%
35.1%
Q4 24
63.0%
36.4%
Q3 24
60.5%
35.6%
Q2 24
61.7%
35.4%
Q1 24
58.1%
36.4%
Operating Margin
APYX
APYX
SUNE
SUNE
Q4 25
0.1%
10.7%
Q3 25
-6.5%
-1.3%
Q2 25
-22.6%
-16.6%
Q1 25
-32.4%
-17.2%
Q4 24
-21.4%
-42.3%
Q3 24
-31.6%
-10.9%
Q2 24
-45.7%
-15.0%
Q1 24
-64.6%
-16.5%
Net Margin
APYX
APYX
SUNE
SUNE
Q4 25
-6.8%
9.6%
Q3 25
-15.4%
-2.1%
Q2 25
-33.2%
-73.5%
Q1 25
-44.0%
-27.7%
Q4 24
-32.5%
-44.4%
Q3 24
-40.9%
-22.4%
Q2 24
-54.0%
-51.2%
Q1 24
-74.0%
9.1%
EPS (diluted)
APYX
APYX
SUNE
SUNE
Q4 25
$105.59
Q3 25
$-0.12
Q2 25
$-3.14
Q1 25
$-106.71
Q4 24
$41676.94
Q3 24
$-2350.12
Q2 24
$-0.19
$-11022.91
Q1 24
$-0.22
$-38414.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
SUNE
SUNE
Cash + ST InvestmentsLiquidity on hand
$31.7M
$7.2M
Total DebtLower is stronger
$37.5M
$6.6M
Stockholders' EquityBook value
$14.5M
$24.3M
Total Assets
$66.8M
$48.2M
Debt / EquityLower = less leverage
2.58×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
SUNE
SUNE
Q4 25
$31.7M
$7.2M
Q3 25
$25.1M
$5.4M
Q2 25
$29.3M
$3.2M
Q1 25
$31.0M
$1.4M
Q4 24
$31.7M
$839.3K
Q3 24
$28.0M
$1.1M
Q2 24
$32.7M
$1.0M
Q1 24
$37.3M
$1.8M
Total Debt
APYX
APYX
SUNE
SUNE
Q4 25
$37.5M
$6.6M
Q3 25
$37.5M
Q2 25
$37.5M
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
SUNE
SUNE
Q4 25
$14.5M
$24.3M
Q3 25
$5.8M
$21.7M
Q2 25
$7.3M
$22.1M
Q1 25
$10.5M
$14.8M
Q4 24
$14.2M
$8.5M
Q3 24
$11.0M
$13.1M
Q2 24
$14.7M
$-10.9M
Q1 24
$20.3M
$-11.2M
Total Assets
APYX
APYX
SUNE
SUNE
Q4 25
$66.8M
$48.2M
Q3 25
$57.4M
$49.6M
Q2 25
$58.2M
$44.1M
Q1 25
$60.2M
$44.4M
Q4 24
$64.8M
$45.7M
Q3 24
$60.7M
$51.0M
Q2 24
$65.4M
$52.9M
Q1 24
$70.7M
$54.7M
Debt / Equity
APYX
APYX
SUNE
SUNE
Q4 25
2.58×
0.27×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
SUNE
SUNE
Operating Cash FlowLast quarter
$-2.5M
$2.1M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
0.81×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
SUNE
SUNE
Q4 25
$-2.5M
$2.1M
Q3 25
$-3.5M
$2.4M
Q2 25
$-1.2M
$-130.2K
Q1 25
$-702.0K
$-3.4M
Q4 24
$-2.9M
$-1.9M
Q3 24
$-4.4M
$-968.1K
Q2 24
$-4.3M
$-776.4K
Q1 24
$-6.3M
$-2.6M
Free Cash Flow
APYX
APYX
SUNE
SUNE
Q4 25
$-2.8M
Q3 25
$-4.1M
$2.4M
Q2 25
$-1.5M
Q1 25
$-757.0K
Q4 24
$-3.2M
$-1.9M
Q3 24
$-4.6M
$-980.3K
Q2 24
$-4.6M
$-788.4K
Q1 24
$-6.4M
$-2.7M
FCF Margin
APYX
APYX
SUNE
SUNE
Q4 25
-14.6%
Q3 25
-31.5%
12.5%
Q2 25
-13.2%
Q1 25
-8.0%
Q4 24
-22.4%
-12.4%
Q3 24
-40.0%
-6.7%
Q2 24
-38.0%
-5.8%
Q1 24
-62.2%
-20.1%
Capex Intensity
APYX
APYX
SUNE
SUNE
Q4 25
1.4%
Q3 25
4.0%
0.0%
Q2 25
2.3%
Q1 25
0.6%
Q4 24
1.7%
0.0%
Q3 24
1.3%
0.1%
Q2 24
2.4%
0.1%
Q1 24
0.3%
0.0%
Cash Conversion
APYX
APYX
SUNE
SUNE
Q4 25
0.81×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-2.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

SUNE
SUNE

Transferred At Point In Time$15.1M55%
Hawaii Energy Connection$10.0M37%
Transferred Over Time$2.1M8%

Related Comparisons